Alternative  	Alternative  	 JJ	B-NP
paths  	paths  	 NNS	I-NP
in  	in  	 IN	O
HIV-1  	HIV-1  	 NNP	B-NP
targeted  	targeted  	 VBD	O
human  	human  	 JJ	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 FW	I-NP
pathways  	pathways  	 FW	I-NP
Human  	Human  	 FW	I-NP
immunodeficiency  	immunodeficiency  	 FW	I-NP
virus-1  	virus-1  	 FW	I-NP
( 	( 	 -LRB-	O
HIV-1 	HIV-1 	 NNP	B-NP
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
a  	a  	 DT	O
minimal  	minimal  	 JJ	O
genome  	genome  	 NN	B-NP
of  	of  	 IN	O
only  	only  	 RB	O
9  	9  	 CD	O
genes 	genes 	 NNS	O
,  	,  	 ,	O
which  	which  	 WDT	O
encode  	encode  	 VBD	O
15  	15  	 CD	O
proteins 	proteins 	 NNS	O
.  	.  	 .	O
HIV-1  	HIV-1  	 NNP	B-NP
thus  	thus  	 RB	O
depends  	depends  	 VBZ	O
on  	on  	 IN	O
the  	the  	 DT	O
human  	human  	 JJ	O
host  	host  	 NN	O
for  	for  	 IN	O
virtually  	virtually  	 RB	O
every  	every  	 DT	O
aspect  	aspect  	 NN	B-NP
of  	of  	 IN	O
its  	its  	 PRP$	O
life  	life  	 NN	B-NP
cycle 	cycle 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
universal  	universal  	 JJ	O
language  	language  	 NN	O
of  	of  	 IN	O
communication  	communication  	 NN	B-NP
in  	in  	 IN	O
biological  	biological  	 JJ	B-NP
systems 	systems 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
between  	between  	 IN	O
pathogen  	pathogen  	 NN	O
and  	and  	 CC	O
host 	host 	 NN	O
,  	,  	 ,	O
is  	is  	 VBZ	O
via  	via  	 IN	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 NN	I-NP
pathways 	pathways 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
fundamental  	fundamental  	 JJ	B-NP
units  	units  	 NNS	I-NP
of  	of  	 IN	O
these  	these  	 DT	O
pathways  	pathways  	 NNS	O
are  	are  	 VBP	O
protein  	protein  	 JJ	B-NP
protein  	protein  	 NN	I-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
Understanding  	Understanding  	 VBG	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
significance  	significance  	 NN	I-NP
of  	of  	 IN	I-NP
HIV-1 	HIV-1 	 NNP	I-NP
,  	,  	 ,	O
human  	human  	 JJ	O
interactions  	interactions  	 NN	B-NP
requires  	requires  	 VBZ	O
viewing  	viewing  	 VBG	O
them  	them  	 PRP	O
in  	in  	 IN	O
the  	the  	 DT	O
context  	context  	 NN	O
of  	of  	 IN	O
human  	human  	 JJ	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 NN	I-NP
pathways 	pathways 	 NN	I-NP
.  	.  	 .	O
Integration  	Integration  	 NN	O
of  	of  	 IN	O
HIV-1 	HIV-1 	 NNP	B-NP
,  	,  	 ,	O
human  	human  	 JJ	O
interactions  	interactions  	 NNS	B-NP
with  	with  	 IN	O
known  	known  	 JJ	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 NN	I-NP
pathways  	pathways  	 NN	I-NP
indicates  	indicates  	 VBZ	O
that  	that  	 IN	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
known  	known  	 VBN	O
human  	human  	 JJ	O
pathways  	pathways  	 NNS	O
have  	have  	 VBP	O
the  	the  	 DT	O
potential  	potential  	 JJ	O
to  	to  	 TO	O
be  	be  	 VB	O
effected  	effected  	 VBN	O
through  	through  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
an  	an  	 DT	O
HIV-1  	HIV-1  	 NNP	B-NP
protein  	protein  	 NN	I-NP
at  	at  	 IN	O
some  	some  	 DT	O
point  	point  	 NN	O
during  	during  	 IN	O
the  	the  	 DT	O
HIV-1  	HIV-1  	 NNP	B-NP
life  	life  	 NN	I-NP
cycle 	cycle 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
each  	each  	 DT	O
pathway 	pathway 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
define  	define  	 VB	O
simple  	simple  	 JJ	O
paths  	paths  	 NNS	O
between  	between  	 IN	O
start  	start  	 NN	B-NP
points  	points  	 NNS	I-NP
( 	( 	 -LRB-	O
i.e.  	i.e.  	 FW	O
no  	no  	 DT	O
edges  	edges  	 NNS	O
going  	going  	 VBG	O
into  	into  	 IN	O
a  	a  	 DT	O
node 	node 	 NN	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
end  	end  	 NN	B-NP
points  	points  	 NNS	I-NP
( 	( 	 -LRB-	O
i.e.  	i.e.  	 FW	O
no  	no  	 FW	O
edges  	edges  	 FW	O
leaving  	leaving  	 FW	O
a  	a  	 FW	O
node 	node 	 FW	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
then  	then  	 RB	O
identify  	identify  	 VB	O
the  	the  	 DT	O
paths  	paths  	 NNS	O
that  	that  	 WDT	O
pass  	pass  	 VBP	O
through  	through  	 IN	O
human  	human  	 JJ	O
proteins  	proteins  	 NNS	O
that  	that  	 IN	O
interact  	interact  	 NN	O
with  	with  	 IN	O
HIV-1  	HIV-1  	 CD	B-NP
proteins 	proteins 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
supplement  	supplement  	 VB	O
the  	the  	 DT	O
combined  	combined  	 JJ	O
map  	map  	 NN	O
with  	with  	 IN	O
functional  	functional  	 JJ	B-NP
information 	information 	 NN	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
which  	which  	 WDT	O
proteins  	proteins  	 NNS	O
are  	are  	 VBP	O
known  	known  	 VBN	O
drug  	drug  	 NN	B-NP
targets  	targets  	 NNS	I-NP
and  	and  	 CC	O
which  	which  	 WDT	O
proteins  	proteins  	 NNS	O
contribute  	contribute  	 VBP	O
significantly  	significantly  	 RB	O
to  	to  	 TO	O
HIV-1  	HIV-1  	 CD	B-NP
function  	function  	 NN	I-NP
as  	as  	 IN	O
revealed  	revealed  	 NN	O
by  	by  	 IN	O
recent  	recent  	 JJ	O
siRNA  	siRNA  	 JJ	B-NP
screens 	screens 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
find  	find  	 VBP	O
that  	that  	 IN	O
there  	there  	 EX	O
are  	are  	 VBP	O
often  	often  	 RB	O
alternative  	alternative  	 JJ	O
paths  	paths  	 NNS	O
starting  	starting  	 VBG	O
and  	and  	 CC	O
ending  	ending  	 VBG	O
at  	at  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
proteins  	proteins  	 NNS	O
but  	but  	 CC	O
circumventing  	circumventing  	 VBG	O
the  	the  	 DT	O
intermediate  	intermediate  	 JJ	O
steps  	steps  	 NNS	O
disrupted  	disrupted  	 VBN	O
by  	by  	 IN	O
HIV-1 	HIV-1 	 NNP	B-NP
.  	.  	 .	O
A  	A  	 DT	O
mapping  	mapping  	 NN	O
of  	of  	 IN	O
HIV-1 	HIV-1 	 NNP	B-NP
,  	,  	 ,	O
human  	human  	 JJ	O
interactions  	interactions  	 NNS	B-NP
to  	to  	 TO	O
human  	human  	 JJ	O
signal  	signal  	 NN	B-NP
transduction  	transduction  	 NN	I-NP
pathways  	pathways  	 NN	I-NP
is  	is  	 VBZ	O
presented  	presented  	 VBN	O
here  	here  	 RB	O
to  	to  	 TO	O
link  	link  	 VB	O
interactions  	interactions  	 VBN	B-NP
with  	with  	 IN	O
functions 	functions 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
proposed  	proposed  	 VBD	O
a  	a  	 DT	O
new  	new  	 JJ	O
way  	way  	 NN	O
of  	of  	 IN	O
analyzing  	analyzing  	 VBG	O
the  	the  	 DT	O
virus  	virus  	 NN	B-NP
host  	host  	 NN	I-NP
interactions  	interactions  	 NNS	I-NP
by  	by  	 IN	O
identifying  	identifying  	 VBG	B-NP
HIV-1  	HIV-1  	 NNP	I-NP
targets  	targets  	 VBZ	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
alternative  	alternative  	 JJ	O
paths  	paths  	 NNS	O
bypassing  	bypassing  	 VBP	O
the  	the  	 DT	O
HIV-1  	HIV-1  	 NNP	B-NP
targeted  	targeted  	 VBD	I-NP
steps 	steps 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
approach  	approach  	 NN	B-NP
yields  	yields  	 NNS	I-NP
numerous  	numerous  	 JJ	O
experimentally  	experimentally  	 JJ	O
testable  	testable  	 JJ	B-NP
hypotheses  	hypotheses  	 NN	I-NP
on  	on  	 IN	O
how  	how  	 WRB	O
HIV-1  	HIV-1  	 NNP	B-NP
function  	function  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
compromised  	compromised  	 VBN	O
and  	and  	 CC	O
human  	human  	 JJ	O
cellular  	cellular  	 JJ	B-NP
function  	function  	 NN	I-NP
restored  	restored  	 VBN	O
by  	by  	 IN	O
pharmacological  	pharmacological  	 JJ	B-NP
approaches 	approaches 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
are  	are  	 VBP	O
making  	making  	 VBG	O
the  	the  	 DT	O
full  	full  	 JJ	O
set  	set  	 NN	O
of  	of  	 IN	O
pathway  	pathway  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
results  	results  	 NNS	I-NP
available  	available  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
community 	community 	 NN	O
.  	.  	 .	O
